Mar 06, 2024 / 09:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the Inovio Fourth Quarter and Year End 2023 financial results conference call. At this time, all lines are in listen-only mode. And following the presentation, we will conduct a question and answer session. If that if at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Wednesday, March sixth, 2024. I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.
Thomas Hong - INOVIO Pharmaceuticals, Inc. - IR
Good afternoon, and thank you for joining the Inovio 2023 Fourth Quarter and Full Year Financial Results Conference Call. Joining me on today's call are Dr. Jacqueline Shea, President and Chief Executive Officer; Dr. Michael Sumner,, Chief Medical Officer; Mark Twyman, Chief Commercial Officer; and Peter Kies, Chief Financial Officer of today's call will review our corporate and financial information for the quarter and full year ended December 31st, 2023, as well as provide a
Q4 2023 Inovio Pharmaceuticals Inc Earnings Call Transcript
Mar 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers